Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation-induced prostatic sarcoma: a case report.

J M Scully1, J M Uno, M McIntyre

  • 1Department of Surgery, Bay Area Hospital, Coos Bay, Oregon.

The Journal of Urology
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Once-daily raltegravir with tenofovir disoproxil/emtricitabine as HIV post-exposure prophylaxis following sexual exposure.

HIV medicine·2020
Same author

Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnostics.

Allergy·2016
Same author

Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Diffuse hair loss associated with hyperprolactinaemia: report of three cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

The putative serine protease inhibitor Api m 6 from Apis mellifera venom: recombinant and structural evaluation.

Journal of investigational allergology & clinical immunology·2013
Same author

Managing HIV in pregnancy in a community-based sexual health clinic: a decade in review.

International journal of STD & AIDS·2012
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

A prostatic sarcoma developed in a patient eight years after prostate cancer treatment. The sarcoma contained metallic particles, likely from the initial 125iodine implants used for prostate cancer therapy.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • A 64-year-old male patient with a history of stage B1N prostate cancer underwent transurethral prostatectomy, bilateral pelvic lymph node dissection, and 125iodine implantation.
  • Eight years post-treatment, the patient developed a prostatic sarcoma.

Observation:

  • The sarcoma was treated with isolated pelvic perfusion followed by pelvic exenteration.
  • Surgical pathology revealed a well-encapsulated, grade 2 spindle cell sarcoma of the prostate.
  • Multiple small metallic particles were noted within the tumor specimen.

Findings:

  • The presence of metallic particles in the sarcoma specimen suggests a potential link to the prior 125iodine brachytherapy.
  • The spindle cell sarcoma represents a rare secondary malignancy following prostate cancer treatment.

Related Experiment Videos

Implications:

  • This case highlights the importance of considering secondary malignancies after radiation therapy for prostate cancer.
  • Further investigation may be warranted to understand the long-term oncogenic potential of radioactive implants.
  • The findings underscore the need for vigilant long-term surveillance in patients treated for prostate cancer.